Response to "Comments on Treatment Strategies and Prognostic Factors of Limited-Stage Primary Small Cell Carcinoma of the Esophagus"

Affiliations

¹ Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, People's Republic of China.
² Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, People's Republic of China. Electronic address: liyin825vip@163.com.

Free article

Comment

Lei Xu et al. J Thorac Oncol. 2018 Feb.

Free article

. 2018 Feb;13(2):e24-e25.

doi: 10.1016/j.jtho.2017.11.120.

¹ Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, People's Republic of China.
² Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, People's Republic of China. Electronic address: liyin825vip@163.com.

No abstract available

Comment on

Treatment Strategies and Prognostic Factors of Limited-Stage Primary Small Cell Carcinoma of the Esophagus.
Xu L, Li Y, Liu X, Sun H, Zhang R, Zhang J, Zheng Y, Wang Z, Liu S, Chen X. Xu L, et al. J Thorac Oncol. 2017 Dec;12(12):1834-1844. doi: 10.1016/j.jtho.2017.09.1966. Epub 2017 Oct 9. J Thorac Oncol. 2017. PMID: 29024756
Comments on "Treatment Strategies and Prognostic Factors of Limited-Stage Primary Small Cell Carcinoma of the Esophagus".
Safiri S, Ayubi E, Mansori K. Safiri S, et al. J Thorac Oncol. 2018 Feb;13(2):e23-e24. doi: 10.1016/j.jtho.2017.10.026. J Thorac Oncol. 2018. PMID: 29425616 No abstract available.